| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 25 | 2023 | 478 | 6.220 |
Why?
|
| Smith-Magenis Syndrome | 18 | 2022 | 126 | 5.370 |
Why?
|
| Intellectual Disability | 37 | 2022 | 1032 | 4.830 |
Why?
|
| Metabolism, Inborn Errors | 8 | 2021 | 108 | 3.520 |
Why?
|
| Abnormalities, Multiple | 24 | 2021 | 998 | 3.330 |
Why?
|
| Chromosomes, Human, Pair 17 | 24 | 2016 | 641 | 2.990 |
Why?
|
| Developmental Disabilities | 10 | 2021 | 674 | 2.460 |
Why?
|
| Trans-Activators | 24 | 2016 | 1555 | 2.260 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 5 | 2023 | 105 | 2.180 |
Why?
|
| Chromosome Deletion | 19 | 2021 | 1005 | 2.120 |
Why?
|
| Neurodevelopmental Disorders | 6 | 2023 | 413 | 2.060 |
Why?
|
| Metabolome | 12 | 2023 | 344 | 2.040 |
Why?
|
| Phenotype | 41 | 2024 | 6295 | 1.860 |
Why?
|
| Haploinsufficiency | 8 | 2016 | 294 | 1.760 |
Why?
|
| Exome | 5 | 2023 | 1239 | 1.630 |
Why?
|
| Biomarkers | 12 | 2021 | 5047 | 1.570 |
Why?
|
| Chromosomes, Human, Pair 2 | 8 | 2021 | 172 | 1.550 |
Why?
|
| Transcription Factors | 22 | 2023 | 5270 | 1.530 |
Why?
|
| DNA-Binding Proteins | 12 | 2023 | 4821 | 1.400 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 3 | 2023 | 17 | 1.370 |
Why?
|
| Craniofacial Abnormalities | 10 | 2021 | 239 | 1.340 |
Why?
|
| Metabolic Diseases | 4 | 2022 | 130 | 1.300 |
Why?
|
| Autism Spectrum Disorder | 7 | 2023 | 363 | 1.280 |
Why?
|
| Mitochondrial Diseases | 5 | 2024 | 137 | 1.260 |
Why?
|
| Circadian Rhythm | 3 | 2015 | 330 | 1.220 |
Why?
|
| Child, Preschool | 41 | 2023 | 16273 | 1.190 |
Why?
|
| Sleep Wake Disorders | 4 | 2021 | 348 | 1.190 |
Why?
|
| Syndrome | 24 | 2015 | 1351 | 1.170 |
Why?
|
| Histone Deacetylases | 4 | 2019 | 365 | 1.070 |
Why?
|
| Microcephaly | 4 | 2024 | 325 | 1.060 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 3 | 2020 | 45 | 1.040 |
Why?
|
| Metabolic Networks and Pathways | 7 | 2023 | 336 | 1.020 |
Why?
|
| Child | 48 | 2024 | 29154 | 1.000 |
Why?
|
| Mutation | 35 | 2022 | 15179 | 1.000 |
Why?
|
| Urea Cycle Disorders, Inborn | 3 | 2023 | 80 | 1.000 |
Why?
|
| Hyperventilation | 2 | 2021 | 19 | 0.980 |
Why?
|
| Hyperphagia | 3 | 2022 | 45 | 0.960 |
Why?
|
| Infant | 28 | 2021 | 13310 | 0.950 |
Why?
|
| Child Development Disorders, Pervasive | 4 | 2015 | 96 | 0.950 |
Why?
|
| Muscle Hypotonia | 3 | 2024 | 180 | 0.910 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2023 | 16 | 0.900 |
Why?
|
| Genotype | 12 | 2023 | 4109 | 0.900 |
Why?
|
| Chromatography, Liquid | 4 | 2020 | 342 | 0.900 |
Why?
|
| Humans | 141 | 2024 | 261506 | 0.860 |
Why?
|
| Racemases and Epimerases | 1 | 2022 | 16 | 0.860 |
Why?
|
| Niacin | 1 | 2022 | 61 | 0.840 |
Why?
|
| Succinate-Semialdehyde Dehydrogenase | 1 | 2021 | 1 | 0.840 |
Why?
|
| NAD | 1 | 2022 | 89 | 0.830 |
Why?
|
| NADP | 1 | 2022 | 96 | 0.830 |
Why?
|
| Phenylbutyrates | 2 | 2023 | 59 | 0.820 |
Why?
|
| Repressor Proteins | 5 | 2019 | 1664 | 0.780 |
Why?
|
| Hand Deformities, Congenital | 3 | 2020 | 87 | 0.780 |
Why?
|
| Transaldolase | 1 | 2020 | 4 | 0.770 |
Why?
|
| Farber Lipogranulomatosis | 1 | 2020 | 1 | 0.760 |
Why?
|
| Transketolase | 1 | 2020 | 18 | 0.760 |
Why?
|
| Acid Ceramidase | 1 | 2020 | 5 | 0.760 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2020 | 13 | 0.750 |
Why?
|
| Adolescent | 35 | 2022 | 31252 | 0.750 |
Why?
|
| Male | 76 | 2024 | 123000 | 0.750 |
Why?
|
| Penetrance | 2 | 2019 | 126 | 0.740 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2020 | 45 | 0.740 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 1084 | 0.740 |
Why?
|
| Self-Injurious Behavior | 4 | 2015 | 54 | 0.710 |
Why?
|
| Female | 71 | 2023 | 141928 | 0.700 |
Why?
|
| Wolman Disease | 1 | 2019 | 7 | 0.690 |
Why?
|
| Sterol Esterase | 1 | 2019 | 17 | 0.690 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 16 | 0.680 |
Why?
|
| Seizures | 7 | 2024 | 989 | 0.650 |
Why?
|
| Zellweger Syndrome | 1 | 2018 | 10 | 0.640 |
Why?
|
| Peroxisomal Disorders | 1 | 2018 | 12 | 0.630 |
Why?
|
| Phenylacetates | 1 | 2017 | 20 | 0.620 |
Why?
|
| Diet, Ketogenic | 1 | 2017 | 22 | 0.620 |
Why?
|
| Carbidopa | 1 | 2017 | 17 | 0.620 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2017 | 48 | 0.620 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2018 | 35 | 0.610 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2017 | 26 | 0.610 |
Why?
|
| Aggression | 2 | 2019 | 252 | 0.600 |
Why?
|
| Levodopa | 1 | 2017 | 92 | 0.590 |
Why?
|
| Pyrroline Carboxylate Reductases | 1 | 2016 | 5 | 0.590 |
Why?
|
| Dopamine Agonists | 1 | 2017 | 85 | 0.590 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 339 | 0.590 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2016 | 18 | 0.590 |
Why?
|
| Neonatal Screening | 2 | 2015 | 165 | 0.580 |
Why?
|
| Glutamine | 2 | 2022 | 299 | 0.580 |
Why?
|
| Cerebrospinal Fluid | 1 | 2017 | 120 | 0.580 |
Why?
|
| Mass Spectrometry | 5 | 2020 | 702 | 0.570 |
Why?
|
| Proteins | 4 | 2006 | 1963 | 0.560 |
Why?
|
| Genetic Variation | 2 | 2020 | 2086 | 0.550 |
Why?
|
| Dopa Decarboxylase | 1 | 2015 | 7 | 0.530 |
Why?
|
| Homozygote | 2 | 2020 | 717 | 0.530 |
Why?
|
| Obesity | 6 | 2022 | 2884 | 0.530 |
Why?
|
| Genetic Counseling | 1 | 2017 | 380 | 0.530 |
Why?
|
| Fluoroquinolones | 6 | 1997 | 126 | 0.530 |
Why?
|
| Problem Behavior | 1 | 2015 | 36 | 0.520 |
Why?
|
| Down Syndrome | 1 | 2017 | 226 | 0.510 |
Why?
|
| Period Circadian Proteins | 1 | 2014 | 52 | 0.510 |
Why?
|
| Gene Deletion | 6 | 2016 | 1442 | 0.510 |
Why?
|
| Prader-Willi Syndrome | 1 | 2015 | 69 | 0.510 |
Why?
|
| Body Fat Distribution | 2 | 2014 | 29 | 0.500 |
Why?
|
| Quinolones | 6 | 1997 | 160 | 0.500 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 761 | 0.500 |
Why?
|
| Leigh Disease | 3 | 2019 | 39 | 0.500 |
Why?
|
| Frameshift Mutation | 4 | 2010 | 220 | 0.490 |
Why?
|
| Autistic Disorder | 4 | 2021 | 319 | 0.480 |
Why?
|
| Mental Disorders | 3 | 2012 | 862 | 0.480 |
Why?
|
| Chromosome Aberrations | 4 | 2016 | 1960 | 0.470 |
Why?
|
| Dietary Carbohydrates | 1 | 2014 | 134 | 0.470 |
Why?
|
| Diet, High-Fat | 2 | 2014 | 241 | 0.460 |
Why?
|
| Spasms, Infantile | 3 | 2022 | 165 | 0.460 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 1209 | 0.440 |
Why?
|
| Child Development | 1 | 2015 | 255 | 0.440 |
Why?
|
| Liver | 3 | 2019 | 2961 | 0.440 |
Why?
|
| Mass Screening | 1 | 2021 | 1509 | 0.440 |
Why?
|
| Sibling Relations | 1 | 2012 | 13 | 0.440 |
Why?
|
| Genetic Testing | 5 | 2020 | 1589 | 0.440 |
Why?
|
| DNA Topoisomerases, Type II | 5 | 1997 | 116 | 0.440 |
Why?
|
| Hemochromatosis | 2 | 2005 | 35 | 0.440 |
Why?
|
| Young Adult | 14 | 2022 | 21445 | 0.430 |
Why?
|
| Trisomy | 1 | 2013 | 231 | 0.420 |
Why?
|
| Mitochondrial Encephalomyopathies | 2 | 2023 | 26 | 0.420 |
Why?
|
| Polymerase Chain Reaction | 6 | 2013 | 3203 | 0.410 |
Why?
|
| Adult | 28 | 2022 | 77950 | 0.410 |
Why?
|
| Veterans | 1 | 2023 | 1641 | 0.410 |
Why?
|
| Anti-Infective Agents | 6 | 1997 | 446 | 0.410 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2005 | 235 | 0.400 |
Why?
|
| Cohort Studies | 8 | 2023 | 9244 | 0.400 |
Why?
|
| Siblings | 1 | 2012 | 285 | 0.380 |
Why?
|
| Haploidy | 1 | 2010 | 40 | 0.380 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 677 | 0.380 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2014 | 176 | 0.370 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 2 | 2021 | 23 | 0.370 |
Why?
|
| Muscular Diseases | 3 | 2015 | 161 | 0.370 |
Why?
|
| Purpura | 2 | 2021 | 31 | 0.360 |
Why?
|
| Behavior | 1 | 2010 | 103 | 0.360 |
Why?
|
| Caregivers | 2 | 2020 | 677 | 0.360 |
Why?
|
| Gene Dosage | 5 | 2013 | 829 | 0.350 |
Why?
|
| Pedigree | 6 | 2022 | 1890 | 0.350 |
Why?
|
| In Situ Hybridization, Fluorescence | 9 | 2022 | 2232 | 0.350 |
Why?
|
| Disease Models, Animal | 8 | 2018 | 7222 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 5539 | 0.350 |
Why?
|
| Sleep | 3 | 2021 | 413 | 0.350 |
Why?
|
| Tandem Mass Spectrometry | 5 | 2020 | 368 | 0.350 |
Why?
|
| Feeding Behavior | 1 | 2015 | 808 | 0.350 |
Why?
|
| Speech Disorders | 1 | 2009 | 91 | 0.340 |
Why?
|
| Alleles | 6 | 2019 | 2437 | 0.330 |
Why?
|
| Maternal Behavior | 1 | 2009 | 62 | 0.330 |
Why?
|
| Haplotypes | 2 | 2009 | 856 | 0.330 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2008 | 32 | 0.320 |
Why?
|
| Animals | 32 | 2023 | 59536 | 0.320 |
Why?
|
| Serotonin | 1 | 2009 | 264 | 0.310 |
Why?
|
| Stereotyped Behavior | 2 | 2019 | 35 | 0.310 |
Why?
|
| Membrane Proteins | 4 | 2023 | 2819 | 0.310 |
Why?
|
| Melatonin | 2 | 2020 | 46 | 0.310 |
Why?
|
| Quality of Life | 2 | 2020 | 4532 | 0.300 |
Why?
|
| Infant, Newborn | 12 | 2020 | 8223 | 0.300 |
Why?
|
| Heterozygote | 5 | 2019 | 1020 | 0.300 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 3343 | 0.300 |
Why?
|
| Moyamoya Disease | 1 | 2007 | 42 | 0.290 |
Why?
|
| Social Behavior | 1 | 2009 | 306 | 0.290 |
Why?
|
| Urea | 2 | 2019 | 290 | 0.290 |
Why?
|
| Mothers | 1 | 2010 | 410 | 0.290 |
Why?
|
| Carnitine | 3 | 2015 | 94 | 0.290 |
Why?
|
| Comparative Genomic Hybridization | 5 | 2013 | 691 | 0.280 |
Why?
|
| Molecular Sequence Data | 12 | 2010 | 6089 | 0.280 |
Why?
|
| Amino Acid Sequence | 9 | 2017 | 4233 | 0.280 |
Why?
|
| Mice | 19 | 2023 | 34495 | 0.280 |
Why?
|
| Growth Disorders | 1 | 2008 | 218 | 0.280 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2015 | 18 | 0.270 |
Why?
|
| Lipid Metabolism, Inborn Errors | 2 | 2015 | 22 | 0.270 |
Why?
|
| Schizophrenia | 1 | 2009 | 369 | 0.270 |
Why?
|
| Foot Deformities, Congenital | 1 | 2005 | 15 | 0.270 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 4053 | 0.270 |
Why?
|
| Mice, Transgenic | 6 | 2012 | 4143 | 0.260 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2009 | 442 | 0.260 |
Why?
|
| Gene Editing | 2 | 2018 | 216 | 0.260 |
Why?
|
| Base Sequence | 11 | 2013 | 4917 | 0.260 |
Why?
|
| Point Mutation | 4 | 2007 | 769 | 0.250 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2015 | 4549 | 0.250 |
Why?
|
| Mice, Knockout | 6 | 2020 | 5710 | 0.250 |
Why?
|
| Neoplasms, Experimental | 1 | 2008 | 750 | 0.250 |
Why?
|
| Child Behavior Disorders | 1 | 2005 | 68 | 0.250 |
Why?
|
| Brain | 8 | 2022 | 4113 | 0.250 |
Why?
|
| Gene Expression | 4 | 2021 | 3570 | 0.240 |
Why?
|
| Arginine-tRNA Ligase | 1 | 2024 | 9 | 0.240 |
Why?
|
| CRISPR-Cas Systems | 2 | 2018 | 323 | 0.240 |
Why?
|
| Polymorphism, Genetic | 3 | 2013 | 1450 | 0.240 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 3154 | 0.240 |
Why?
|
| Facies | 2 | 2021 | 149 | 0.230 |
Why?
|
| Stroke | 2 | 2023 | 1144 | 0.230 |
Why?
|
| Acidosis, Lactic | 1 | 2023 | 33 | 0.230 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 610 | 0.230 |
Why?
|
| MELAS Syndrome | 1 | 2023 | 37 | 0.230 |
Why?
|
| Epilepsy | 1 | 2011 | 883 | 0.230 |
Why?
|
| Tyrosine | 2 | 2015 | 498 | 0.230 |
Why?
|
| Limit of Detection | 3 | 2018 | 78 | 0.230 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2015 | 2508 | 0.220 |
Why?
|
| Stress, Psychological | 1 | 2010 | 1000 | 0.220 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 22 | 0.210 |
Why?
|
| Epileptic Syndromes | 1 | 2022 | 26 | 0.210 |
Why?
|
| DNA Copy Number Variations | 4 | 2016 | 1516 | 0.210 |
Why?
|
| DNA Mutational Analysis | 4 | 2016 | 2283 | 0.210 |
Why?
|
| Apyrase | 1 | 2022 | 44 | 0.210 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 30 | 0.210 |
Why?
|
| Genetic Carrier Screening | 2 | 2015 | 92 | 0.210 |
Why?
|
| Chromosome Disorders | 3 | 2013 | 417 | 0.210 |
Why?
|
| Prevalence | 4 | 2023 | 3260 | 0.210 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1995 | 621 | 0.200 |
Why?
|
| Carrier Proteins | 2 | 2020 | 2022 | 0.200 |
Why?
|
| Anti-Anxiety Agents | 1 | 2022 | 90 | 0.200 |
Why?
|
| Sequence Alignment | 2 | 2017 | 844 | 0.200 |
Why?
|
| Retrospective Studies | 8 | 2023 | 37905 | 0.200 |
Why?
|
| Epilepsy, Generalized | 1 | 2022 | 71 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 6 | 2015 | 6942 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2022 | 181 | 0.200 |
Why?
|
| Grenada | 1 | 2020 | 2 | 0.200 |
Why?
|
| Information Theory | 1 | 2021 | 9 | 0.200 |
Why?
|
| Anemia, Sideroblastic | 1 | 2021 | 58 | 0.200 |
Why?
|
| Uncertainty | 1 | 2023 | 320 | 0.190 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 1998 | 57 | 0.190 |
Why?
|
| Riboflavin Deficiency | 1 | 2020 | 8 | 0.190 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 2020 | 8 | 0.190 |
Why?
|
| Anemia, Macrocytic | 1 | 2020 | 12 | 0.190 |
Why?
|
| Liver Transplantation | 2 | 2020 | 1112 | 0.190 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 341 | 0.190 |
Why?
|
| Riboflavin | 1 | 2020 | 26 | 0.190 |
Why?
|
| Internationality | 1 | 2021 | 208 | 0.190 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2020 | 69 | 0.190 |
Why?
|
| Case-Control Studies | 5 | 2015 | 6100 | 0.190 |
Why?
|
| Thymidine Phosphorylase | 1 | 2020 | 23 | 0.190 |
Why?
|
| De Lange Syndrome | 1 | 2020 | 43 | 0.190 |
Why?
|
| Topoisomerase II Inhibitors | 4 | 1995 | 58 | 0.180 |
Why?
|
| Dopamine | 2 | 2023 | 312 | 0.180 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 644 | 0.180 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 201 | 0.180 |
Why?
|
| Histidine | 2 | 2022 | 91 | 0.180 |
Why?
|
| Pierre Robin Syndrome | 1 | 2020 | 28 | 0.180 |
Why?
|
| Loss of Heterozygosity | 1 | 2021 | 602 | 0.180 |
Why?
|
| White Matter | 1 | 2022 | 195 | 0.180 |
Why?
|
| Fibroblasts | 3 | 2019 | 1682 | 0.170 |
Why?
|
| Genetic Pleiotropy | 1 | 2019 | 29 | 0.170 |
Why?
|
| Genome, Human | 4 | 2019 | 1869 | 0.170 |
Why?
|
| Somnambulism | 1 | 2019 | 2 | 0.170 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2019 | 8 | 0.170 |
Why?
|
| Chromosome Mapping | 7 | 2000 | 1471 | 0.170 |
Why?
|
| Dynamins | 1 | 2019 | 74 | 0.170 |
Why?
|
| Hybrid Cells | 4 | 2000 | 128 | 0.170 |
Why?
|
| Psychopathology | 1 | 2019 | 33 | 0.170 |
Why?
|
| Serine | 2 | 2017 | 388 | 0.170 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 144 | 0.170 |
Why?
|
| INDEL Mutation | 1 | 2019 | 112 | 0.170 |
Why?
|
| Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2018 | 7 | 0.160 |
Why?
|
| Sulfite Oxidase | 1 | 2018 | 4 | 0.160 |
Why?
|
| Molybdenum | 1 | 2018 | 19 | 0.160 |
Why?
|
| Pre-Eclampsia | 1 | 2021 | 212 | 0.160 |
Why?
|
| Genes, Recessive | 1 | 2019 | 200 | 0.160 |
Why?
|
| Rare Diseases | 1 | 2021 | 351 | 0.160 |
Why?
|
| GTP-Binding Proteins | 1 | 2000 | 321 | 0.160 |
Why?
|
| Sphingomyelins | 1 | 2018 | 33 | 0.160 |
Why?
|
| Genetic Linkage | 1 | 2000 | 512 | 0.160 |
Why?
|
| Acyltransferases | 1 | 2018 | 62 | 0.160 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 9 | 0.160 |
Why?
|
| Genetic Services | 1 | 2017 | 7 | 0.160 |
Why?
|
| Hyperammonemia | 2 | 2015 | 68 | 0.160 |
Why?
|
| Argininosuccinate Lyase | 1 | 2018 | 66 | 0.160 |
Why?
|
| Psychomotor Disorders | 1 | 2017 | 32 | 0.160 |
Why?
|
| Restriction Mapping | 1 | 1998 | 264 | 0.160 |
Why?
|
| Aorta, Thoracic | 1 | 2023 | 546 | 0.160 |
Why?
|
| Vanilmandelic Acid | 1 | 2017 | 10 | 0.160 |
Why?
|
| Gene Duplication | 2 | 2011 | 421 | 0.160 |
Why?
|
| Urinalysis | 1 | 2018 | 84 | 0.150 |
Why?
|
| Transaminases | 1 | 2017 | 76 | 0.150 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2017 | 34 | 0.150 |
Why?
|
| Aspirin | 1 | 2021 | 455 | 0.150 |
Why?
|
| Dihydropteridine Reductase | 1 | 2017 | 4 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 4314 | 0.150 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 144 | 0.150 |
Why?
|
| Arginine | 2 | 2023 | 500 | 0.150 |
Why?
|
| Glycerol | 1 | 2017 | 99 | 0.150 |
Why?
|
| Cells, Cultured | 6 | 2015 | 5637 | 0.150 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2017 | 52 | 0.150 |
Why?
|
| Ammonia | 1 | 2017 | 88 | 0.150 |
Why?
|
| Edetic Acid | 1 | 2017 | 73 | 0.150 |
Why?
|
| DNA, Superhelical | 1 | 1997 | 23 | 0.150 |
Why?
|
| Citric Acid Cycle | 1 | 2017 | 86 | 0.150 |
Why?
|
| HLA Antigens | 1 | 2000 | 546 | 0.150 |
Why?
|
| Growth Charts | 1 | 2016 | 14 | 0.150 |
Why?
|
| Cysteine | 1 | 2018 | 214 | 0.150 |
Why?
|
| Tyrosinemias | 1 | 2016 | 22 | 0.150 |
Why?
|
| Symporters | 1 | 2017 | 98 | 0.140 |
Why?
|
| Overweight | 2 | 2022 | 484 | 0.140 |
Why?
|
| Adaptation, Psychological | 2 | 2012 | 764 | 0.140 |
Why?
|
| Codon | 1 | 2016 | 241 | 0.140 |
Why?
|
| Cell Line | 3 | 2016 | 5114 | 0.140 |
Why?
|
| Blood Specimen Collection | 1 | 2017 | 93 | 0.140 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 1995 | 9 | 0.140 |
Why?
|
| Homocysteine | 1 | 2016 | 138 | 0.140 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 118 | 0.140 |
Why?
|
| Myelin Proteins | 1 | 2016 | 90 | 0.140 |
Why?
|
| Methionine | 1 | 2016 | 159 | 0.140 |
Why?
|
| Dietary Supplements | 2 | 2017 | 558 | 0.140 |
Why?
|
| Mitochondria | 2 | 2020 | 1282 | 0.140 |
Why?
|
| Hyperargininemia | 1 | 2015 | 13 | 0.140 |
Why?
|
| Actins | 1 | 1999 | 608 | 0.140 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2015 | 8 | 0.130 |
Why?
|
| Glycine | 1 | 2017 | 289 | 0.130 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 338 | 0.130 |
Why?
|
| Erythrocytes | 1 | 2017 | 339 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2019 | 403 | 0.130 |
Why?
|
| Obesity Hypoventilation Syndrome | 1 | 2015 | 2 | 0.130 |
Why?
|
| Exons | 4 | 2016 | 1328 | 0.130 |
Why?
|
| Ellipticines | 1 | 1995 | 2 | 0.130 |
Why?
|
| Arginase | 1 | 2015 | 48 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2017 | 621 | 0.130 |
Why?
|
| Acetylserotonin O-Methyltransferase | 1 | 2015 | 1 | 0.130 |
Why?
|
| Protein Kinases | 1 | 1999 | 874 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 915 | 0.130 |
Why?
|
| Cryptochromes | 1 | 2014 | 14 | 0.130 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 1399 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 259 | 0.130 |
Why?
|
| Behavior, Animal | 2 | 2009 | 709 | 0.130 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 67 | 0.130 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2017 | 238 | 0.130 |
Why?
|
| Social Support | 1 | 2017 | 560 | 0.130 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2015 | 63 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 462 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2017 | 448 | 0.120 |
Why?
|
| Citrullinemia | 1 | 2014 | 19 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 2216 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2021 | 2218 | 0.120 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 5159 | 0.120 |
Why?
|
| Radiation Tolerance | 1 | 1998 | 629 | 0.120 |
Why?
|
| Hypothalamic Diseases | 1 | 2015 | 66 | 0.120 |
Why?
|
| Blotting, Southern | 2 | 2008 | 406 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2014 | 6150 | 0.120 |
Why?
|
| Xenopus | 1 | 2014 | 219 | 0.120 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2014 | 126 | 0.120 |
Why?
|
| Fasting | 1 | 2015 | 349 | 0.120 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 501 | 0.120 |
Why?
|
| Family | 1 | 2017 | 736 | 0.120 |
Why?
|
| Autophagy | 1 | 2020 | 927 | 0.120 |
Why?
|
| Xenopus laevis | 1 | 2014 | 270 | 0.120 |
Why?
|
| Xenopus Proteins | 1 | 2014 | 185 | 0.120 |
Why?
|
| Translocation, Genetic | 3 | 2022 | 1245 | 0.110 |
Why?
|
| Receptors, Prolactin | 1 | 2013 | 27 | 0.110 |
Why?
|
| Fragile X Syndrome | 1 | 2014 | 150 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 1506 | 0.110 |
Why?
|
| Hemochromatosis Protein | 2 | 2005 | 23 | 0.110 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 134 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2007 | 997 | 0.110 |
Why?
|
| Brachydactyly | 1 | 2012 | 10 | 0.110 |
Why?
|
| Oscillometry | 1 | 2012 | 26 | 0.110 |
Why?
|
| Aged | 4 | 2023 | 70117 | 0.110 |
Why?
|
| CHO Cells | 3 | 1999 | 311 | 0.110 |
Why?
|
| Middle Aged | 5 | 2022 | 86204 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 224 | 0.110 |
Why?
|
| CLOCK Proteins | 1 | 2012 | 35 | 0.110 |
Why?
|
| Body Weight | 2 | 2014 | 1293 | 0.110 |
Why?
|
| Algorithms | 2 | 2021 | 3890 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 3639 | 0.110 |
Why?
|
| Physicians | 1 | 2020 | 882 | 0.100 |
Why?
|
| DNA | 4 | 2006 | 2693 | 0.100 |
Why?
|
| Cell Cycle | 1 | 1998 | 2084 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 7702 | 0.100 |
Why?
|
| Cricetinae | 3 | 1999 | 706 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 6009 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2017 | 992 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2013 | 104 | 0.100 |
Why?
|
| Disease Progression | 2 | 2020 | 6682 | 0.100 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 1294 | 0.100 |
Why?
|
| CpG Islands | 2 | 2011 | 633 | 0.100 |
Why?
|
| DNA Primers | 3 | 2013 | 1399 | 0.100 |
Why?
|
| Satiety Response | 1 | 2010 | 33 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 402 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 3101 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 591 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2012 | 255 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 590 | 0.090 |
Why?
|
| Mutation, Missense | 4 | 2019 | 1152 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2014 | 1244 | 0.090 |
Why?
|
| Litter Size | 1 | 2009 | 26 | 0.090 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 376 | 0.090 |
Why?
|
| Mice, Congenic | 1 | 2008 | 30 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2010 | 392 | 0.090 |
Why?
|
| Signal Transduction | 3 | 2021 | 11965 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 4 | 2015 | 2483 | 0.090 |
Why?
|
| Hearing Loss | 1 | 2010 | 153 | 0.080 |
Why?
|
| Attitude to Health | 1 | 2012 | 465 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 1724 | 0.080 |
Why?
|
| Mitochondrial Proteins | 2 | 2023 | 369 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 241 | 0.080 |
Why?
|
| Arachidonate 12-Lipoxygenase | 2 | 1998 | 17 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2016 | 1616 | 0.080 |
Why?
|
| Recombinant Proteins | 6 | 2015 | 2927 | 0.080 |
Why?
|
| Citrulline | 2 | 2023 | 108 | 0.080 |
Why?
|
| trans-Golgi Network | 1 | 2008 | 11 | 0.080 |
Why?
|
| Pregnancy | 4 | 2021 | 7573 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3230 | 0.080 |
Why?
|
| Molecular Probe Techniques | 1 | 2008 | 46 | 0.080 |
Why?
|
| Selection, Genetic | 1 | 2008 | 189 | 0.080 |
Why?
|
| Degenerin Sodium Channels | 1 | 2007 | 5 | 0.080 |
Why?
|
| Acid Sensing Ion Channels | 1 | 2007 | 6 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 1546 | 0.080 |
Why?
|
| Sheep | 1 | 2008 | 258 | 0.080 |
Why?
|
| COS Cells | 1 | 2008 | 377 | 0.080 |
Why?
|
| Epithelial Sodium Channels | 1 | 2007 | 31 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2291 | 0.080 |
Why?
|
| Precision Medicine | 1 | 2015 | 1154 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2007 | 78 | 0.070 |
Why?
|
| Oxidoreductases | 2 | 2018 | 171 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2008 | 292 | 0.070 |
Why?
|
| Language Development Disorders | 1 | 2008 | 167 | 0.070 |
Why?
|
| Transgenes | 1 | 2008 | 557 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2008 | 294 | 0.070 |
Why?
|
| Multigene Family | 1 | 2008 | 425 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 233 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 4971 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 542 | 0.070 |
Why?
|
| Kinetics | 4 | 1997 | 2049 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2010 | 1489 | 0.070 |
Why?
|
| Radiography | 1 | 2010 | 1904 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 4744 | 0.070 |
Why?
|
| Cell Survival | 1 | 1992 | 3045 | 0.070 |
Why?
|
| Anxiety | 1 | 2013 | 1179 | 0.070 |
Why?
|
| Spleen | 1 | 2008 | 676 | 0.070 |
Why?
|
| Protein Transport | 1 | 2008 | 734 | 0.070 |
Why?
|
| Hepatocytes | 2 | 2018 | 351 | 0.070 |
Why?
|
| Parents | 1 | 2012 | 998 | 0.070 |
Why?
|
| Michigan | 1 | 2005 | 67 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 4320 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2005 | 331 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2007 | 613 | 0.060 |
Why?
|
| Linear Models | 2 | 2018 | 1085 | 0.060 |
Why?
|
| United States | 2 | 2019 | 15433 | 0.060 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2005 | 82 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2023 | 51 | 0.060 |
Why?
|
| Fetus | 2 | 2014 | 601 | 0.060 |
Why?
|
| Disease Management | 2 | 2019 | 1052 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2008 | 1732 | 0.060 |
Why?
|
| DNA, Complementary | 3 | 1999 | 869 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2005 | 424 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2005 | 574 | 0.050 |
Why?
|
| Dilatation | 1 | 2023 | 83 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 24 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5061 | 0.050 |
Why?
|
| Computational Biology | 1 | 2009 | 1271 | 0.050 |
Why?
|
| Transcriptome | 2 | 2021 | 1859 | 0.050 |
Why?
|
| Paraplegia | 1 | 2022 | 95 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2014 | 1764 | 0.050 |
Why?
|
| Family Health | 1 | 2003 | 325 | 0.050 |
Why?
|
| Nitrogen | 1 | 2022 | 162 | 0.050 |
Why?
|
| Gene Amplification | 1 | 2005 | 731 | 0.050 |
Why?
|
| Sex Factors | 1 | 2007 | 2139 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2005 | 1163 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2021 | 82 | 0.050 |
Why?
|
| Chromosome Banding | 2 | 1999 | 256 | 0.050 |
Why?
|
| Glutathione | 1 | 2023 | 368 | 0.050 |
Why?
|
| Benzofurans | 1 | 2021 | 38 | 0.050 |
Why?
|
| West Indies | 1 | 2020 | 8 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2021 | 88 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 1265 | 0.050 |
Why?
|
| Computer Graphics | 1 | 2021 | 82 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2022 | 164 | 0.050 |
Why?
|
| Time | 1 | 2021 | 178 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 208 | 0.050 |
Why?
|
| Supratentorial Neoplasms | 1 | 2001 | 78 | 0.050 |
Why?
|
| Esophageal Motility Disorders | 1 | 2020 | 9 | 0.050 |
Why?
|
| Automation | 1 | 2020 | 151 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2001 | 226 | 0.050 |
Why?
|
| Sequence Tagged Sites | 1 | 2000 | 33 | 0.050 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2001 | 100 | 0.050 |
Why?
|
| Thymidine | 1 | 2020 | 155 | 0.050 |
Why?
|
| Amsacrine | 2 | 1997 | 61 | 0.050 |
Why?
|
| Expressed Sequence Tags | 1 | 2000 | 101 | 0.050 |
Why?
|
| Amino Acids | 1 | 2023 | 728 | 0.050 |
Why?
|
| Etoposide | 3 | 1997 | 870 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2020 | 162 | 0.050 |
Why?
|
| COP9 Signalosome Complex | 1 | 1999 | 72 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 460 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2021 | 181 | 0.040 |
Why?
|
| Genistein | 2 | 1997 | 73 | 0.040 |
Why?
|
| Electron Transport | 1 | 2019 | 79 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 1491 | 0.040 |
Why?
|
| Electron Transport Complex IV | 1 | 2019 | 57 | 0.040 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Isoflavones | 2 | 1997 | 72 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 29902 | 0.040 |
Why?
|
| Fingers | 1 | 2020 | 120 | 0.040 |
Why?
|
| Transcription Factor 4 | 1 | 2019 | 36 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 203 | 0.040 |
Why?
|
| Clinical Chemistry Tests | 1 | 2018 | 12 | 0.040 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2018 | 10 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2019 | 49 | 0.040 |
Why?
|
| Time Factors | 3 | 2018 | 12926 | 0.040 |
Why?
|
| Consanguinity | 1 | 2019 | 114 | 0.040 |
Why?
|
| Mammals | 1 | 2020 | 361 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2003 | 1113 | 0.040 |
Why?
|
| Coenzymes | 1 | 2018 | 16 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2021 | 4078 | 0.040 |
Why?
|
| Luciferases | 1 | 1999 | 445 | 0.040 |
Why?
|
| Fever | 1 | 2021 | 497 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 319 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 416 | 0.040 |
Why?
|
| Pseudogenes | 1 | 1998 | 81 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 1013 | 0.040 |
Why?
|
| Gestational Age | 1 | 2021 | 1069 | 0.040 |
Why?
|
| Prognosis | 2 | 2020 | 21713 | 0.040 |
Why?
|
| DEAD Box Protein 58 | 1 | 2017 | 14 | 0.040 |
Why?
|
| Otitis | 1 | 2017 | 8 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 82 | 0.040 |
Why?
|
| Suppression, Genetic | 1 | 1997 | 67 | 0.040 |
Why?
|
| Epidermis | 1 | 1998 | 188 | 0.040 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2017 | 51 | 0.040 |
Why?
|
| Citric Acid | 1 | 2017 | 54 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 336 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 589 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1995 | 611 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 488 | 0.040 |
Why?
|
| Nitrobenzoates | 1 | 2016 | 15 | 0.040 |
Why?
|
| Ataxia Telangiectasia | 1 | 1997 | 62 | 0.040 |
Why?
|
| Cyclohexanones | 1 | 2016 | 30 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 548 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1999 | 1555 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 1997 | 14289 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 1997 | 89 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 942 | 0.040 |
Why?
|
| Plasmids | 1 | 2018 | 837 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 538 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2020 | 393 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 2001 | 434 | 0.030 |
Why?
|
| Hydrolases | 1 | 2016 | 123 | 0.030 |
Why?
|
| Plasma | 1 | 2017 | 158 | 0.030 |
Why?
|
| Sinusitis | 1 | 2017 | 131 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1997 | 515 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 521 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1995 | 97 | 0.030 |
Why?
|
| Medulloblastoma | 1 | 2001 | 540 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2021 | 2588 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 137 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2016 | 185 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 309 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2015 | 18 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 1995 | 218 | 0.030 |
Why?
|
| DNA Damage | 2 | 1994 | 1954 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2020 | 899 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2017 | 374 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1999 | 1234 | 0.030 |
Why?
|
| Metoclopramide | 1 | 1994 | 33 | 0.030 |
Why?
|
| Facial Bones | 1 | 2014 | 40 | 0.030 |
Why?
|
| Argininosuccinate Synthase | 1 | 2014 | 54 | 0.030 |
Why?
|
| Chondrogenesis | 1 | 2014 | 67 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2015 | 213 | 0.030 |
Why?
|
| Genetic Markers | 1 | 1997 | 974 | 0.030 |
Why?
|
| Neural Crest | 1 | 2014 | 85 | 0.030 |
Why?
|
| Ileum | 1 | 1994 | 165 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 898 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1999 | 3536 | 0.030 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 123 | 0.030 |
Why?
|
| Chile | 1 | 2013 | 61 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 860 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 1995 | 519 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1995 | 587 | 0.030 |
Why?
|
| NAV1.3 Voltage-Gated Sodium Channel | 1 | 2012 | 3 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2014 | 469 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1993 | 279 | 0.030 |
Why?
|
| NF-kappa B | 1 | 1999 | 1549 | 0.030 |
Why?
|
| Binding Sites | 1 | 1997 | 2171 | 0.030 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2012 | 26 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 1439 | 0.030 |
Why?
|
| Skull | 1 | 2014 | 231 | 0.030 |
Why?
|
| DNA Replication | 1 | 2016 | 744 | 0.030 |
Why?
|
| Cattle | 1 | 1993 | 783 | 0.030 |
Why?
|
| Sodium Channels | 1 | 2012 | 109 | 0.030 |
Why?
|
| Tretinoin | 1 | 2014 | 623 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1993 | 931 | 0.030 |
Why?
|
| Chromosome Duplication | 1 | 2012 | 157 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 2045 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2013 | 332 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1077 | 0.020 |
Why?
|
| Cell Death | 1 | 1993 | 671 | 0.020 |
Why?
|
| Cloning, Molecular | 3 | 1998 | 1213 | 0.020 |
Why?
|
| Pneumonia | 1 | 2017 | 751 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 1997 | 829 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2001 | 2669 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 1183 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 1992 | 423 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1945 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 2803 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 1529 | 0.020 |
Why?
|
| Zebrafish | 1 | 2012 | 463 | 0.020 |
Why?
|
| Neurons | 2 | 2017 | 2287 | 0.020 |
Why?
|
| Age Factors | 1 | 2019 | 5377 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1995 | 1203 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2021 | 32848 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 1879 | 0.020 |
Why?
|
| Benzamides | 1 | 1994 | 1832 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 1498 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8865 | 0.020 |
Why?
|
| Trinucleotide Repeats | 1 | 2006 | 106 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 2466 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 201 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 14551 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 2265 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 3719 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 7226 | 0.010 |
Why?
|
| Iodine Radioisotopes | 2 | 1995 | 371 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 6550 | 0.010 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 1998 | 13 | 0.010 |
Why?
|
| X-Rays | 1 | 1997 | 146 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 1070 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1997 | 250 | 0.010 |
Why?
|
| Introns | 1 | 1998 | 432 | 0.010 |
Why?
|
| Phylogeny | 1 | 1998 | 826 | 0.010 |
Why?
|
| Receptors, Interleukin-8B | 1 | 1995 | 56 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 1995 | 84 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1995 | 300 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1997 | 726 | 0.010 |
Why?
|
| Tryptophan | 1 | 1995 | 127 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 293 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 261 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 236 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 1994 | 68 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1994 | 241 | 0.010 |
Why?
|
| Chemokines | 1 | 1995 | 314 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1994 | 96 | 0.010 |
Why?
|
| Models, Structural | 1 | 1994 | 103 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 777 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 875 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1994 | 218 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1994 | 236 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1994 | 553 | 0.010 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1992 | 22 | 0.010 |
Why?
|
| Trichloroacetic Acid | 1 | 1992 | 6 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 410 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1992 | 329 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 1618 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 568 | 0.010 |
Why?
|
| Rabbits | 1 | 1992 | 957 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 4938 | 0.000 |
Why?
|
| Rats | 1 | 1992 | 6086 | 0.000 |
Why?
|
| Apoptosis | 1 | 1997 | 7591 | 0.000 |
Why?
|